Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biologica
about
Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica.Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.
P2860
Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biologica
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Anti-JCV serology during natal ...... etween technical and biologica
@en
type
label
Anti-JCV serology during natal ...... etween technical and biologica
@en
prefLabel
Anti-JCV serology during natal ...... etween technical and biologica
@en
P2093
P2860
P50
P356
P1476
Anti-JCV serology during natal ...... and biological sero-converters
@en
P2093
John F Foley
Luisa Klotz
Sven G Meuth
Tammy Hoyt
P2860
P304
P356
10.1177/1352458517728814
P577
2017-08-29T00:00:00Z